| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |